Upregulation of glycolytic enzymes and abnormal expression of specific glucose transporters (GLUT-1 to 4) and sodium glucose transporter 1 (SGLT1) were associated with enhanced proliferation and metastasis of human CRC (8–10). The gene discussed is SLC5A1; the disease is colorectal carcinoma.